2-17515931-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000399080.3(RAD51AP2):c.2485T>A(p.Tyr829Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000892 in 1,602,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000399080.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAD51AP2 | NM_001099218.3 | c.2485T>A | p.Tyr829Asn | missense_variant | 1/3 | ENST00000399080.3 | NP_001092688.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAD51AP2 | ENST00000399080.3 | c.2485T>A | p.Tyr829Asn | missense_variant | 1/3 | 1 | NM_001099218.3 | ENSP00000382030.2 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151916Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000184 AC: 43AN: 234176Hom.: 0 AF XY: 0.000181 AC XY: 23AN XY: 126838
GnomAD4 exome AF: 0.0000903 AC: 131AN: 1450450Hom.: 0 Cov.: 34 AF XY: 0.000114 AC XY: 82AN XY: 721010
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151916Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74228
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.2485T>A (p.Y829N) alteration is located in exon 1 (coding exon 1) of the RAD51AP2 gene. This alteration results from a T to A substitution at nucleotide position 2485, causing the tyrosine (Y) at amino acid position 829 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at